Weiman He
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Physiology top 10%
- Adipose Tissue and Metabolism
Papers in ⓘ
-
- RNA modifications and cancer 2
- Circular RNAs in diseases 2
-
- Thyroid Cancer Diagnosis and Treatment 3
- Co-authors
- Ronald M. Evans (1 shared paper)Yaacov Barak (1 shared paper)Jerrold M. Olefsky (1 shared paper)Philip D.G. Miles (1 shared paper)Haipeng Xiao (9 shared papers)Yanbing Li (7 shared papers)Li Xiong (3 shared papers)Yingying Gong (3 shared papers)
- Journals
- Endocrinology (2 papers)Molecular Therapy (1 paper)Frontiers in Oncology (1 paper)Frontiers in Endocrinology (1 paper)Calcified Tissue International (1 paper)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Weiman He
11 papers receiving 519 citations
Peers
Comparison fields: 5 of 52
- Cancer Research 120
- Physiology 203
- Molecular Biology 421
- Biochemistry 43
- Endocrinology, Diabetes and Metabolism 56
Countries citing papers authored by Weiman He
This map shows the geographic impact of Weiman He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiman He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiman He more than expected).
Fields of papers citing papers by Weiman He
This network shows the impact of papers produced by Weiman He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiman He. The network helps show where Weiman He may publish in the future.
Co-authors
The 25 scholars most cited alongside Weiman He, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 341 | |
| 2 | 2021 | 81 | |
| 3 | 2021 | 25 | |
| 4 | 2022 | 24 | |
| 5 | 2020 | 19 | |
| 6 | 2021 | 14 | |
| 7 | 2023 | 8 | |
| 8 | 2023 | 8 | |
| 9 | 2023 | 7 | |
| 10 | 2023 | 3 | |
| 11 | 2023 | 1 |
About Weiman He
Weiman He is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism, Cancer Research, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 11 papers that have together received 531 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (4 papers), Thyroid Cancer Diagnosis and Treatment (3 papers), MicroRNA in disease regulation (2 papers), Genetic factors in colorectal cancer (2 papers), RNA modifications and cancer (2 papers), Ferroptosis and cancer prognosis (2 papers), Circular RNAs in diseases (2 papers) and Metabolism and Genetic Disorders (1 paper). The work is most often cited by research in Cancer Research (120 citations), Physiology (203 citations), Molecular Biology (421 citations), Biochemistry (43 citations) and Endocrinology, Diabetes and Metabolism (56 citations). Weiman He has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Ronald M. Evans, Yaacov Barak, Jerrold M. Olefsky, Philip D.G. Miles, Haipeng Xiao, Yanbing Li, Li Xiong, Yingying Gong, Lei Su and Rengyun Liu. Their work appears in journals such as Endocrinology, Molecular Therapy, Frontiers in Oncology, Frontiers in Endocrinology and Calcified Tissue International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.